Pharmaceutical Executive December 11, 2025
Key Takeaways
- President Trump’s initiatives include an executive order and TrumpRx, aiming to simplify and bring transparency to drug pricing.
- Experts believe these efforts will have limited immediate impact on drug prices due to the complexity of the pricing system.
- The initiatives may increase transparency, exposing high markups and potentially leading to better scrutiny and cheaper healthcare.
- Direct-to-consumer programs are seen as an additional route for therapy access, with limited immediate impact on drug listing and purchasing.
Will the politically fueled reforms and mandates around drug pricing reduce the complexity of the system?
While pharmaceutical pricing has been a controversial topic for many years, a new spotlight was shone on it over the past 12 months.
During...
Today's Sponsors
Today's Sponsor